ONCOLOGY
May 17, 2019
Acute Myeloid Leukemia: From Molecular Pathogenesis to Oral Targeted Therapies
The frequent occurrence of mutations and gene alterations has spurred the development of novel agents for the treatment of AML, including new oral targeted therapies that have recently received regulatory approval.January 18, 2019
Monoclonal Antibody Applications in Bio-Oncology
December 12, 2018
Here’s Why So Few Women at High Risk of Breast Cancer Take Tamoxifen
November 20, 2018
CAR-T Cells: Driving a New Era of Oncology Immunotherapy
October 31, 2018
Full Adherence to Tamoxifen Therapy Found to Be Surprisingly Low
September 14, 2018
Role of PARP Inhibitors in BRCA-Related Malignancies
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.